Undervalued Drug Manufacturer Stocks on TSX March 2025

March 09, 2025

Drug Manufacturers

Drug Manufacturers are engaged in pharmaceutical manufacturing or sale of a diverse line of drug and healthcare products. This industry group also includes companies engaged in the development and discovery of new dugs, and tobacco and cannabis companies.

TSX Venture Exchange

The TSX Venture Exchange is a stock exchange headquartered in Calgary, Alberta, Canada. It is an exchange for the securities of early-stage businesses.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued Drug Manufacturers stocks

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
PCLO PharmaCielo 0.09 0.18 115.83 54431 14 0.00 0.0
LFST Lifeist Wellness 0.04 0.06 70.17 24082 1 0.00 0.0
CANB CanadaBis Cap 0.07 0.11 43.35 77155 10 0.00 0.0
DB Decibel Cannabis Co 0.07 0.10 30.35 371001 31 0.00 0.0
ROMJ Rubicon Organics 0.45 0.54 19.03 49378 26 0.00 0.0
MUSH Mercanto Holdings 0.06 0.07 13.75 29446 3 0.00 0.0
LSL LSL Pharma Group 0.32 0.35 7.89 54676 37 0.00 0.0
RX Biosyent 10.92 11.75 7.60 1822 129 1.69 18.2
LOVE Cannara Biotech 1.31 1.41 7.49 51248 120 0.00 16.4
DHB Delivra Health Brands 0.16 0.17 7.02 39002 5 0.00 0.0
All data provided as at market close March 06, 2025.

Company Details

PharmaCielo

PCLO:TSX-V

Close Price

0.09

Our Valuation

0.18

% Difference

115.83

Market Cap ($M)

14

P/E Ratio

0.0

PharmaCielo Ltd is a pharma company, with a focus on ethical and sustainable processing and supplying of both THC(tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. It is licensed to produce both CBD-dominant and THC-dominant cannabis extracts. The company operates in Canada, Colombia, Italy, and Mexico. It generates the majority of its revenue in the form of the Sale of Cannabis derivative products in Colombia.

Access the stockcalc valuation


Lifeist Wellness

LFST:TSX-V

Close Price

0.04

Our Valuation

0.06

% Difference

70.17

Market Cap ($M)

1

P/E Ratio

0.0

Lifeist Wellness Inc is a portfolio wellness company leveraging advancements in science and technology. Its portfolio of brands includes; CannMart Inc, a distributor of licensed and in-house branded adult-use cannabis and cannabis-derived products in Canada; CannMart Marketplace Inc operates CannMart.com, an online marketplace for hemp-derived CBD and accessories in the U.S.

Access the stockcalc valuation


CanadaBis Cap

CANB:TSX-V

Close Price

0.07

Our Valuation

0.11

% Difference

43.35

Market Cap ($M)

10

P/E Ratio

0.0

CanadaBis Capital Inc is a vertically integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extract. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards.

Access the stockcalc valuation


Decibel Cannabis Co

DB:TSX-V

Close Price

0.07

Our Valuation

0.10

% Difference

30.35

Market Cap ($M)

31

P/E Ratio

0.0

Decibel Cannabis Co Inc is engaged in the cannabis operations business. It is involved in the production, distribution, and sale of recreational cannabis. All the revenues are generated in Canada. The company's revenue is comprised of wholesale sales of both products and services through its production facilities to distributors and licensed cannabis producers as well as the direct sale of products through its retail locations to end customers.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Rubicon Organics

ROMJ:TSX-V

Close Price

0.45

Our Valuation

0.54

% Difference

19.03

Market Cap ($M)

26

P/E Ratio

0.0

Rubicon Organics Inc is engaged in the business of the production and sale of cannabis in Canada. The Company produces and processes organic cannabis at its wholly-owned, federally licensed facility in Delta, British Columbia which it sells under its wholly owned and other licensed brands such as Lab Theory, Wildflower, Homestead Cannabis Supply, 1964 Supply Co, and Simply Bare Organic.

Access the stockcalc valuation


Mercanto Holdings

MUSH:TSX-V

Close Price

0.06

Our Valuation

0.07

% Difference

13.75

Market Cap ($M)

3

P/E Ratio

0.0

Mercanto Holdings Inc operates a portfolio of brands that include traditional cannabis and beverage products. The company exists to promote the use of mushrooms through its brands; The company offers quality products that promote health, recreation, and well-being. The portfolio of the company includes different cannabis products, probiotic, functional mushroom beverages, and others.

Access the stockcalc valuation


LSL Pharma Group

LSL:TSX-V

Close Price

0.32

Our Valuation

0.35

% Difference

7.89

Market Cap ($M)

37

P/E Ratio

0.0

LSL Pharma Group Inc integrated pharmaceutical company specializing in the development, manufacture and distribution of high-quality natural health products and dietary supplements in solid dosage forms as well as high quality sterile ophthalmic pharmaceutical products.

Access the stockcalc valuation


Biosyent

RX:TSX-V

Close Price

10.92

Our Valuation

11.75

% Difference

7.60

Market Cap ($M)

129

P/E Ratio

18.2

Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product includes FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Repagyn, and Tibella.m.

Access the stockcalc valuation


Cannara Biotech

LOVE:TSX-V

Close Price

1.31

Our Valuation

1.41

% Difference

7.49

Market Cap ($M)

120

P/E Ratio

16.4

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building.

Access the stockcalc valuation


Delivra Health Brands

DHB:TSX-V

Close Price

0.16

Our Valuation

0.17

% Difference

7.02

Market Cap ($M)

5

P/E Ratio

0.0

Delivra Health Brands Inc helping people take control of health with alternative wellness solutions. Its portfolio features brands like Dream Water and LivRelief that deliver relief from common, everyday issues like chronic pain, anxiety, and sleeplessness. The principal activities of the company are to provide lifestyle and health and wellness products to consumers and patients in regulated markets.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
PharmaCielo and Lifeist Wellness are the most undervalued Drug Manufacturers stocks on the TSX. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-drug-manufacturer-stocks-tsx-march-2025
PharmaCielo $PCLO and Lifeist Wellness $LFST are the most undervalued Drug Manufacturers stocks on the #TSX. See the full list: https://www.stockcalc.com/Blog/undervalued-drug-manufacturer-stocks-tsx-march-2025
PharmaCielo and Lifeist Wellness are the most undervalued Drug Manufacturers stocks on the TSX. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-drug-manufacturer-stocks-tsx-march-2025

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.